Key Highlights
•
A novel covalent inhibitor fragment for the SARS-CoV-2 main protease has been identified using a target-specific deep learning approach. This discovery offers a promising new avenue for developing antiviral drugs against COVID-19 by precisely targeting a key enzyme in the virus’s replication cycle.
Source →
Stay curious. Stay informed —
Science Briefing
